Site Search
Search Results
Community Letter Urging Congress to Enact Diagnostic Oversight Reform
Leading health care companies and organizations representing patients, providers, laboratories and diagnostic manufacturers called on Senate and House leaders to ... innovative diagnostics and clinical laboratory tests to market. In a letter to the Chairmen and Ranking members of the Senate Committee on Health, Education, Labor & Pensions (HELP) and House Energy and Commerce Committee, more than 80 organizations urged Congress to prioritize ...
Survivor Views on Artificial Intelligence and FDA Medical Product Reviews
... of cancer patients and survivors agree that the industries making FDA-regulated products should provide some of the cost of FDA’s public health oversight Cancer patients and survivors mirror the American public in their hesitancy to embrace AI, with 51% reporting they are more ... excited about the technology compared to only 5% who are more excited than concerned. Respondents have mixed expectations of the impact of AI on health care, with a plurality (39%) predicting the impact over the next 20 years to be equally positive and negative. Cancer patients and survivors offer ...
Priority Issue
State
Policy Issue
- (-) Remove Research, Funding and Drug Development filter Research, Funding and Drug Development